These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 21974700

  • 1. Long-term efficacy and safety of the small-sized β2-microglobulin adsorption column for dialysis-related amyloidosis.
    Yamamoto Y, Hirawa N, Yamaguchi S, Ogawa N, Takeda H, Shibuya K, Kawahara K, Kojima H, Dobashi Y, Fujita M, Azusima K, Miyazaki N, Kobayashi M, Kobayashi C, Fujiwara A, Yuto J, Saka S, Yatsu K, Toya Y, Yasuda G, Ohnishi T, Umemura S.
    Ther Apher Dial; 2011 Oct; 15(5):466-74. PubMed ID: 21974700
    [Abstract] [Full Text] [Related]

  • 2. Effect of beta(2)-microglobulin adsorption column on dialysis-related amyloidosis.
    Abe T, Uchita K, Orita H, Kamimura M, Oda M, Hasegawa H, Kobata H, Fukunishi M, Shimazaki M, Abe T, Akizawa T, Ahmad S.
    Kidney Int; 2003 Oct; 64(4):1522-8. PubMed ID: 12969174
    [Abstract] [Full Text] [Related]

  • 3. Arresting dialysis-related amyloidosis: a prospective multicenter controlled trial of direct hemoperfusion with a beta2-microglobulin adsorption column.
    Gejyo F, Kawaguchi Y, Hara S, Nakazawa R, Azuma N, Ogawa H, Koda Y, Suzuki M, Kaneda H, Kishimoto H, Oda M, Ei K, Miyazaki R, Maruyama H, Arakawa M, Hara M.
    Artif Organs; 2004 Apr; 28(4):371-80. PubMed ID: 15084199
    [Abstract] [Full Text] [Related]

  • 4. Survey of the effects of a column for adsorption of β2-microglobulin in patients with dialysis-related amyloidosis in Japan.
    Gejyo F, Amano I, Ando T, Ishida M, Obayashi S, Ogawa H, Ono T, Kanno Y, Kitaoka T, Kukita K, Kurihara S, Sato M, Shin J, Suzuki M, Takahashi S, Taguma Y, Takemoto Y, Nakazawa R, Nakanishi T, Nakamura H, Hara S, Hiramatsu M, Furuya R, Masakane I, Tsuchida K, Motomiya Y, Morita H, Yamagata K, Yoshiya K, Yamakawa T, Society of β2-Microglobulin Adsorption Therapy.
    Ther Apher Dial; 2013 Feb; 17(1):40-7. PubMed ID: 23379492
    [Abstract] [Full Text] [Related]

  • 5. Beta2-microglobulin-selective adsorbent column (Lixelle) for the treatment of dialysis-related amyloidosis.
    Suzuki K, Shimazaki M, Kutsuki H.
    Ther Apher Dial; 2003 Feb; 7(1):104-7. PubMed ID: 12921124
    [Abstract] [Full Text] [Related]

  • 6. beta(2)-Microglobulin-selective direct hemoperfusion column for the treatment of dialysis-related amyloidosis.
    Kutsuki H.
    Biochim Biophys Acta; 2005 Nov 10; 1753(1):141-5. PubMed ID: 16168723
    [Abstract] [Full Text] [Related]

  • 7. Long-term complications of dialysis: pathogenic factors with special reference to amyloidosis.
    Gejyo F, Homma N, Arakawa M.
    Kidney Int Suppl; 1993 Jun 10; 41():S78-82. PubMed ID: 8320951
    [Abstract] [Full Text] [Related]

  • 8. [Diagnostic and therapeutic aspects of dialysis-related amyloidosis].
    Kopeć J.
    Przegl Lek; 2006 Jun 10; 63(7):567-72. PubMed ID: 17203811
    [Abstract] [Full Text] [Related]

  • 9. Effectiveness of β(2)-microglobulin adsorption column in treating dialysis-related amyloidosis: a multicenter study.
    Kuragano T, Inoue T, Yoh K, Shin J, Fujita Y, Yoshiya K, Kim JI, Sakai R, Sekita K, Goto T, Fukagawa M, Nakanishi T.
    Blood Purif; 2011 Jun 10; 32(4):317-22. PubMed ID: 21934303
    [Abstract] [Full Text] [Related]

  • 10. New adsorption column (Lixelle) to eliminate beta2-microglobulin for direct hemoperfusion.
    Furuyoshi S, Nakatani M, Taman J, Kutsuki H, Takata S, Tani N.
    Ther Apher; 1998 Feb 10; 2(1):13-7. PubMed ID: 10227783
    [Abstract] [Full Text] [Related]

  • 11. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
    Traut M, Haufe CC, Eismann U, Deppisch RM, Stein G, Wolf G.
    Blood Purif; 2007 Feb 10; 25(5-6):432-40. PubMed ID: 17957097
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Performance of the newer type (Lixelle Type S-15) on direct hemoperfusion beta-2-microglobulin adsorption column for dialysis-related amyloidosis.
    Hiyama E, Hyodo T, Kondo M, Otsuka K, Honma T, Taira T, Yoshida K, Uchida T, Endo T, Sakai T, Baba S, Hidai H.
    Nephron; 2002 Oct 10; 92(2):501-2. PubMed ID: 12218344
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Uraemic itching: do polymethylmethacrylate dialysis membranes play a role?
    Aucella F, Vigilante M, Gesuete A, Maruccio G, Specchio A, Gesualdo L.
    Nephrol Dial Transplant; 2007 Jul 10; 22 Suppl 5():v8-12. PubMed ID: 17586845
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.